Prestige Consumer Healthcare Inc. (NYSE:PBH) Given Average Rating of “Moderate Buy” by Analysts

Shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) have been given an average recommendation of “Moderate Buy” by the five brokerages that are currently covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating on the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $92.60.

Several analysts have recently weighed in on PBH shares. Raymond James raised shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research note on Thursday, December 19th. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Sidoti downgraded shares of Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 price objective for the company. in a research note on Monday, December 9th. StockNews.com raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. Finally, Oppenheimer boosted their price objective on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of PBH. Creative Planning grew its holdings in Prestige Consumer Healthcare by 32.6% in the third quarter. Creative Planning now owns 10,011 shares of the company’s stock worth $722,000 after purchasing an additional 2,460 shares during the last quarter. Blue Trust Inc. grew its holdings in Prestige Consumer Healthcare by 102.4% in the third quarter. Blue Trust Inc. now owns 1,755 shares of the company’s stock worth $121,000 after purchasing an additional 888 shares during the last quarter. Raymond James & Associates grew its holdings in Prestige Consumer Healthcare by 3.7% in the third quarter. Raymond James & Associates now owns 122,144 shares of the company’s stock worth $8,807,000 after purchasing an additional 4,342 shares during the last quarter. Sequoia Financial Advisors LLC grew its holdings in Prestige Consumer Healthcare by 12.9% in the third quarter. Sequoia Financial Advisors LLC now owns 9,824 shares of the company’s stock worth $708,000 after purchasing an additional 1,120 shares during the last quarter. Finally, Private Advisor Group LLC grew its holdings in Prestige Consumer Healthcare by 15.6% in the third quarter. Private Advisor Group LLC now owns 3,380 shares of the company’s stock worth $244,000 after purchasing an additional 457 shares during the last quarter. 99.95% of the stock is owned by hedge funds and other institutional investors.

Prestige Consumer Healthcare Stock Up 1.0 %

Shares of NYSE:PBH opened at $84.61 on Friday. The business has a 50 day simple moving average of $80.04 and a two-hundred day simple moving average of $77.14. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. Prestige Consumer Healthcare has a 1 year low of $62.35 and a 1 year high of $88.36. The firm has a market capitalization of $4.19 billion, a PE ratio of 19.81, a price-to-earnings-growth ratio of 2.69 and a beta of 0.50.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, February 6th. The company reported $1.22 earnings per share for the quarter, beating the consensus estimate of $1.18 by $0.04. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. On average, equities analysts predict that Prestige Consumer Healthcare will post 4.5 EPS for the current year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.